News
PTJA14 – Pretomanid in combination with bedaquiline and linezolid in adults for the treatment of pulmonary extensively drug-resistant (XDR), or treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB) – Final assessment now available
This is the pharmaceutical Joint Assessment PTJA14 – Pretomanid in combination with bedaquiline and linezolid in adults for the treatment of pulmonary extensively drug-resistant (XDR),
RCR01-RCR15 Covid-19 Rolling Collaborative Review – Second round of reviews now available
As part of its response to the Covid-19 pandemic, EUnetHTA is working to output ‘Rolling Collaborative Reviews (RCR)’. The objective of such reviews is to
Final Week – EUnetHTA Open Call for Early Dialogue Requests
The EUnetHTA ED Secretariat is holding an Open Call to fill the slots available for EDs through May 31, 2021. EUnetHTA will aim to conduct
OTCA23 Final Assessment Report “Biodegradable rectum spacers to reduce toxicity for prostate cancer” now available
The Other Technologies Collaborative Assessment OTCA23 final assessment report “Biodegradable rectum spacers to reduce toxicity for prostate cancer”, together with related documentation, is now available
PTJA12 – Glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (AML) in adult patients who are not candidates for standard induction chemotherapy – Final assessment now available
This is the pharmaceutical Joint Assessment PTJA12 – on glasdegib for the treatment of acute myeloid leukaemia (AML). In June 2020, the European Commission granted
EUnetHTA Implementation – Final Report now available
The Final Report on Implementation, a deliverable of EUnetHTA Joint Action 3 (2016-2021), explores the use of joint assessments (JA) and collaborative assessments (CA) during
EUnetHTA Covid-19 Response
To help in the development of a coordinated response to the Covid-19 pandemic, it is essential that researched, timely and reliable information can be made
EUnetHTA Open Call for Early Dialogue Requests
The EUnetHTA ED Secretariat is holding an Open Call to fill the slots available for EDs through May 31, 2021. EUnetHTA will aim to conduct
OTCA24 Final Assessment Report now available.
The final assessment report and related documentation is now available for Rapid Relative Effectiveness Assessment OTCA24 ‘The 24-hour blood pressure measurement device Mobil-O- Graph® with
EUnetHTA Early Dialogues – Status during EUnetHTA prolongation period
The current pandemic situation has put additional strain on European health systems and HTA bodies have not been immune to this impact. The unfortunate result
